Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cancer Drug Prices Higher in US Than Europe; Don’t Correlate With Clinical Benefit

Key clinical point: Cancer drug prices are higher in the United States than in Europe, and they don’t correlate with clinical benefit in either region.

Major finding: Median cancer drug prices were 52% lower in Europe than in the United States. No association was found between the price differential and either American Society of Clinical Oncology Value Framework (P = .599) or European Society for Medical Oncology Magnitude of Clinical Benefit Scale (P = .321) scores.

Study details: An analysis of costs and value-related scores for 63 cancer drugs.

Disclosures: The study was funded by the Swiss Cancer League. The authors reported having no conflicts of interest.


Vokinger KN et al. ESMO 2019, Abstract 1631PD-PR.